Inhibitors of multidrug resistant efflux systems in bacteria.
about
New Perspectives on the Use of Phytochemicals as an Emergent Strategy to Control Bacterial Infections Including BiofilmsRecent Advances in Multi-Drug Resistance (MDR) Efflux Pump Inhibitors of Gram-Positive Bacteria S. aureusRecent advances toward a molecular mechanism of efflux pump inhibitionBacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance DeterminantsCombinations of β-lactam or aminoglycoside antibiotics with plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureusIdentification of novel leads applying in silico studies for Mycobacterium multidrug resistant (MMR) protein.Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux PumpsInfluence of efflux pump inhibitors on the multidrug resistance of Helicobacter pylori.Microbial efflux pump inhibition: tactics and strategies.Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitorsCorrelation of ciprofloxacin resistance with the AdeABC efflux system in Acinetobacter baumannii clinical isolates.In vitro and in vivo antibacterial activities of cranberry press cake extracts alone or in combination with β-lactams against Staphylococcus aureus.Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogensUDP-N-acetylmuramic acid l-alanine ligase (MurC) inhibition in a tolC mutant Escherichia coli strain leads to cell deathThe challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosaThe Influence of Efflux Pump Inhibitors on the Activity of Non-Antibiotic NSAIDS against Gram-Negative Rods.Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro.Multiple envelope stress response pathways are activated in an Escherichia coli strain with mutations in two members of the DedA membrane protein family.A report on infection dynamics of inducible clindamycin resistance of Staphylococcus aureus isolated from a teaching hospital in India.Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells.Lipid complexes with cationic peptides and OAKs; their role in antimicrobial action and in the delivery of antimicrobial agents.Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.Bacterial resistance to cationic antimicrobial peptides.Efflux pump-mediated resistance in chemotherapy.Principles of biofouling protection in marine sponges: a model for the design of novel biomimetic and bio-inspired coatings in the marine environment?Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation.Potential Mechanism of Action of 3'-Demethoxy-6-O-demethyl-isoguaiacin on Methicillin Resistant Staphylococcus aureus.Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors.1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors.Prevalence of antimicrobial resistance in faecal enterococci from vet-visiting pets and assessment of risk factors.The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria.Antibacterial and Antibiotic-Modifying Activity of Methanol Extracts from Six Cameroonian Food Plants against Multidrug-Resistant Enteric Bacteria.The Effects of Berberine and Palmatine on Efflux Pumps Inhibition with Different Gene Patterns in Pseudomonas aeruginosa Isolated from Burn Infections.A TolC-Like Protein of Actinobacillus pleuropneumoniae Is Involved in Antibiotic Resistance and Biofilm Formation.Effect of Efflux Pump Inhibitor Carbonyl Cyanide 3-Chlorophenylhydrazone on the Minimum Inhibitory Concentration of Ciprofloxacin in Acinetobacter baumannii Clinical Isolates.Expression of MexAB-OprM efflux pump system and susceptibility to antibiotics of different Pseudomonas aeruginosa clones isolated from patients hospitalized in two intensive care units at University Hospital in Bialystok (northeastern Poland) betweeDiscovery and optimization of a new class of pyruvate kinase inhibitors as potential therapeutics for the treatment of methicillin-resistant Staphylococcus aureus infections.Transcriptomic Analyses Elucidate Adaptive Differences of Closely Related Strains of Pseudomonas aeruginosa in Fuel
P2860
Q26741342-E7D478F0-64CA-4A14-948D-FE1F1B5CA05DQ26829852-9631E66B-54A0-4827-BC75-9A5A0229E322Q27004685-79574FE4-D76E-476A-A69F-881E47FDE670Q28073636-9115A117-EEDF-40C3-9C5C-659D8538CEEDQ28543476-9C0DC25E-98E9-4E90-A0F1-9BC573208AE4Q31141792-91B2BEC3-FED6-47E2-9D27-1CF242BBD9E7Q33659230-3FADFC03-3AFC-4F5E-AF2B-304371C17D4AQ33730293-D767388D-814D-44EA-BBC1-D680509599B6Q34176211-FB7BEE66-B12B-4829-ADEF-68EDC3298FC0Q34299161-F165B631-CA10-4C35-9111-169D2128AF8AQ34431949-2027253D-2E66-4644-8D62-0EB6E7F85478Q34690899-E6C4DE1F-1339-4D9C-8E02-462DE9AB368EQ35131669-20FDE24A-03FC-465B-9115-6A849D981A03Q35223217-7A2DC5B8-25B0-4FF0-BFC3-A3C857698395Q35482558-5BA5BB00-DBAA-457D-9C4F-395215C36984Q35830489-6D44EC8F-3DD5-4ECC-B1D0-5220833BC31DQ35895154-E604048F-ECEC-4000-95B0-FF9BBA923539Q36075871-31F48558-386B-4CF1-BB5B-3F1F322CEFC9Q36506233-B4B80561-7587-45B0-BC8A-6A418D15A9C4Q36768169-FA651DDA-E62A-4103-BA98-4018AA8003D0Q36850409-929BBB05-51ED-442E-8FB8-D242D02D5E62Q37875766-A775C38C-C04D-4DF1-9969-D6AC862F7F1CQ38011247-E90885D8-0A6F-4503-818D-C5EDC6E5F857Q38026594-29F57550-77C0-4B3D-BC47-09B9F067AD52Q38084554-A6962113-5500-4D07-B17D-EBE2CCC7FAD3Q38092725-A5FB108A-BC2D-4C81-82F8-F1BFC0BD4A78Q38247296-EEA19F4D-3E53-4A68-8D73-7C11F664E0B6Q38297573-A13AFE51-3FCA-48A2-997A-F367D31CCD35Q38599969-62311793-90E6-42B2-B0CE-C08EB681EC53Q38715925-BE4E1CD4-28E6-4B18-A53E-C43064E36122Q39010675-64BE6A81-F91E-48DA-8EE1-94E6A5FB1AE7Q39169713-0C142863-89B1-4190-B669-0ACCE8A60430Q39358619-45E60741-0A89-4596-8C86-48EDFF807455Q40047406-6F09F850-4489-4E18-A055-6212951ED039Q40370889-1CEEF812-FD14-4A6F-9ED6-C7DCFA080D02Q40460603-D8ED9C41-316D-4E7A-9E82-8C670139E2A0Q41934962-DD87C132-F176-4296-A693-333846FDA55BQ42224064-E019DE61-375E-4FCA-8C67-F9F39418B2EEQ42229272-42629B49-A2FB-4D6D-87AD-CB639FD1E8F9Q42580259-1BEC2A09-CD45-430D-9138-DB2A7F7E4832
P2860
Inhibitors of multidrug resistant efflux systems in bacteria.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibitors of multidrug resistant efflux systems in bacteria.
@en
Inhibitors of multidrug resistant efflux systems in bacteria.
@nl
type
label
Inhibitors of multidrug resistant efflux systems in bacteria.
@en
Inhibitors of multidrug resistant efflux systems in bacteria.
@nl
prefLabel
Inhibitors of multidrug resistant efflux systems in bacteria.
@en
Inhibitors of multidrug resistant efflux systems in bacteria.
@nl
P1476
Inhibitors of multidrug resistant efflux systems in bacteria.
@en
P2093
Barbara Zechini
Ilaria Versace
P356
10.2174/157489109787236256
P577
2009-01-01T00:00:00Z